Concepedia

Days Supply Limits

Days Supply Limits is a quantity control mechanism that restricts the maximum number of days’ worth of medication dispensed at one time to ensure adherence, prevent overuse, and manage pharmaceutical utilization within healthcare systems.

8

Publications

224

Citations

30

Authors

15

Institutions

Publications per year

2017–2026

2

Parents

Publications

8

Medication Days’ Supply, Adherence, Wastage, and Cost Among Chronic Patients in Medicaid

Michael Taitel, Leonard Fensterheim, Heather Kirkham et al. · Medicare & Medicaid Research Review · 2012 · 70 citations · Full text

, , +17

Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting

Brian Meissner, Digisha Trivedi, Min You et al. · Journal of Medical Economics · 2014 · 43 citations

, , +16

Methodological Considerations in Estimating Adherence and Persistence for a Long-Acting Injectable Medication

Elizabeth J. Campagna, Erik Muser, Joseph Parks et al. · Journal of Managed Care Pharmacy · 2014 · 30 citations · Full text

, , +14

Examination of Days Supply in Computerized Prescription Claims

Karen B. Farris · Journal of Pharmacoepidemiology · 1994 · 21 citations

, , +8

Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence

Krutika Amin, Joel F. Farley, Matthew L. Maciejewski et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 17 citations · Full text

, , +15

1–5 of 8

Authors

30

  1. MD
    Malcolm Dobbin

    Monash University, Australia

    1 publications · 12 citations

    1

    h-index

  2. JF
    Joel F. Farley

    University of North Carolina at Chapel Hill, United States

    1 publications · 17 citations

    1

    h-index

  3. SN
    Suzanne Nielsen

    UNSW Sydney, Australia

    1 publications · 12 citations

    1

    h-index

  4. KA
    Krutika Amin

    University of Pittsburgh, United States

    1 publications · 17 citations

    1

    h-index

  5. DG
    Daniel Galanto

    Massachusetts Department of Public Health, United States

    1 publications · 14 citations

    1

    h-index

1–5 of 30

Institutions

15

  1. Institute for Clinical Evaluative Sciences

    Toronto, Canada

    1 h-index

    2 publications

    34 citations

  2. University of Colorado Anschutz Medical Campus

    Aurora, United States

    1 h-index

    1 publications

    30 citations

  3. Duke Medical Center

    Durham, United States

    1 h-index

    1 publications

    17 citations

  4. Boston Medical Center

    Boston, United States

    1 h-index

    1 publications

    14 citations

  5. University of Toronto

    Toronto, Canada

    1 h-index

    3 publications

    51 citations

  6. University of North Carolina at Chapel Hill

    Chapel Hill, United States

    1 h-index

    2 publications

    34 citations

  7. Bristol-Myers Squibb (Germany)

    Munich, Germany

    1 h-index

    4 publications

    172 citations

  8. Boston University

    Boston, United States

    1 h-index

    2 publications

    28 citations

1–8 of 15

Venues

  1. Journal of Pharmacoepidemiology

    1 publications · 21 citations

    1

    h-index

  2. Archives of Osteoporosis

    1 publications · 17 citations

    1

    h-index

  3. 1

    h-index

  4. Journal of Managed Care Pharmacy

    JMCP · 1 publications · 30 citations

    1

    h-index

  5. Medicare & Medicaid Research Review

    MMRR · 1 publications · 70 citations

    1

    h-index

1–5